Nel ASA's Quiet Stretch Masks a Pivotal Product Bet
Published on 08/17/2026 at 19:51 | Redaktion boerse-global.de
The Norwegian hydrogen specialist has slipped into an unusually subdued phase. Two weeks have passed without fresh order announcements, insider dealings, or analyst revisions — a stark departure from the recent flurry of activity that saw JPMorgan trim its price target, second-quarter results land, and a leadership transition take shape. The shares now trade at EUR 0.1982, down roughly one percent over the past month.
The PA-Series: A Platform Built on Radical Cost Reduction
Beneath the surface calm, the company's strategic focus has sharpened around its newest generation of pressurized alkaline electrolyzers. Launched in May and fleshed out during the earnings call roughly a month ago, the PA-Series represents a significant leap in efficiency: floor space requirements drop by 80 percent compared with the previous generation, while capital expenditures fall by 40 to 60 percent. The pitch to customers is straightforward — lower cost per kilogram of hydrogen produced, the metric that increasingly dictates purchasing decisions in the electrolyzer market.
Management expects the first orders for the platform to materialize in the coming months. That timing matters, because the economics of the business hinge on scale. The company has been explicit about the thresholds: alkaline technology needs annual sales of several hundred megawatts to reach profitability, while the PEM line requires capacity utilization of 20 to 24 percent. Current volumes remain well short of those markers, which is why the PA-Series order pipeline has become the single most important variable for investors to watch.
Scaling up industrial operations brings its own set of risks — and the same discipline that guides capacity planning should apply to workplace safety. A free toolkit with 41 ready-to-use templates and checklists helps you document hazards and keep your compliance obligations in order as your business grows. Download the free Risk Assessment Toolkit
Capacity Expansion Backed by EU Funding
The production ramp is already underway, supported by a EUR 135 million grant from the EU Innovation Fund awarded in late October 2024. A first milestone payment from that facility arrived in the second quarter of 2026, signaling that the project is advancing on schedule. Manufacturing capacity is slated to reach 500 megawatts by the end of 2026, with a target of one gigawatt the following year.
The expansion at the Herøya site, where the company is scaling up its pressurized alkaline platform, forms the operational backbone of this push. But the financial picture remains mixed. Second-quarter revenue from customer contracts came in at NOK 153 million, with order intake of NOK 230 million and a backlog of NOK 1.213 billion. The operating result, however, landed at minus NOK 155 million, weighed down in part by a NOK 70 million settlement with Japanese partner Iwatani.
Leadership Transition Adds Another Layer
The earnings release also carried news of a change at the top: CEO Håkon Volldal will remain in his role until the end of 2026, after which he will step down. The announcement has kept investors engaged even as the immediate share-price reaction has faded. The leadership question now sits alongside the profitability challenge as a medium-term overhang.
A Market Waiting for Catalysts
The stock's recent trajectory reflects the absence of fresh catalysts. Friday's close of EUR 0.2025 gave way to a 2.1 percent decline in the latest session, though the 30-day picture shows a gain of 3.1 percent — evidence of partial stabilization following the JPMorgan target cut in early August, even if that call is now several weeks old and no longer represents the prevailing analyst view.
The secondary article notes a slightly different 30-day performance of 5.4 percent and a year-to-date advance of 7.3 percent, with the shares still sitting 45 percent below the 52-week high of EUR 0.3655 reached in May. The stock trades just under its 50-day moving average of EUR 0.2105, while a relative strength index of 48 points to a market without strong directional conviction.
As you track operational milestones, don't overlook the safety documentation that keeps your workforce protected. Over 37,000 UK businesses rely on a free Health & Safety toolkit covering everything from fire protection to COSHH compliance — all ready to download and implement immediately. Get the free Health & Safety Toolkit
For now, the investment case rests on a familiar tension: persistent operating losses and thin profitability against a growing order book and advancing production capacity. Without new orders, partnerships, or analyst commentary, the share price is likely to track broader sentiment in the hydrogen sector rather than company-specific news.
Two dates stand out on the calendar. The first is August 27, when Cavendish is scheduled to report — an event that could indirectly influence Nel's valuation. The second is the company's own third-quarter report on October 21, which will offer the clearest evidence yet on whether the PA-Series is converting technical promise into commercial traction.
